Revolune Announces Commercial Availability of Multiplex Immunofluorescence Reagents

Contributed by: PR Newswire

Tags

REVOLUNE-PDTS-elect

More Like This

PR Newswire associated0

Revolune GmbH Launches to Simplify Spatial Biology with Streamlined Multiplex Immunofluorescence Solutions

PR Newswire associated0

Revolune and MindPeak to Showcase Integrated Multiplex Immunofluorescence Workflow at AACR 2026

PR Newswire associated0

Revolune and Propath UK Bring Service-Backed Multiplex immunofluorescence Workflows to Biopharma Customers

PR Newswire associated0

Revolune Announces Service Provider Program with CellCarta, Concept Life Sciences, and Propath UK

Evosep Unveils Groundbreaking Innovations in Scalable Proteomics Workflows at ASMS 2024

Business Wire logo

Fujirebio and Agappe Enter into an Agreement on Business Collaboration in the Field of CLIA Based Immunoassay

Business Wire logo

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only

MGI Tech Launches VisiOmics in Europe and Unveils AI-Enabled Pathology Portfolio at ECP 2026